TY - JOUR
T1 - Potential activities to reduce the extent of substandard and falsified antibiotics across Africa and associated antimicrobial resistance
AU - Maluleke, Tiyani Milta
AU - Mekonnen, Biset Asrade
AU - Ubaka, Chukwuemeka Michael
AU - Paramadhas, Bene D.Anand
AU - Munzhedzi, Mukhethwa
AU - Kalungia, Aubrey Chichonyi
AU - Hango, Ester
AU - Kumar, Santosh
AU - Godman, Brian
AU - Meyer, Johanna C.
N1 - Publisher Copyright:
Copyright © 2025 Maluleke, Mekonnen, Ubaka, Paramadhas, Munzhedzi, Kalungia, Hango, Kumar, Godman and Meyer.
PY - 2025
Y1 - 2025
N2 - Antimicrobial resistance (AMR) is a global public health threat exacerbated by inappropriate antibiotic use. This is particularly important in Africa. The availability of substandard and falsified antibiotics, particularly among African countries, contributes to this adding to the burden of AMR. Poor monitoring and regulatory controls among African countries increases the public health risks of these antibiotics. This is especially the case in the informal sector. Addressing Africa’s battle against substandard and falsified antibiotics requires an integrated approach building on current WHO, Interpol and Pan-African initiatives. Activities include harmonizing regulatory activities across Africa and increasing the monitoring of available antibiotics as well as fines and sanctions for offenders. In addition, reducing the current high levels of inappropriate antibiotic use makes the market for falsified and substandard antibiotics considerably less attractive.
AB - Antimicrobial resistance (AMR) is a global public health threat exacerbated by inappropriate antibiotic use. This is particularly important in Africa. The availability of substandard and falsified antibiotics, particularly among African countries, contributes to this adding to the burden of AMR. Poor monitoring and regulatory controls among African countries increases the public health risks of these antibiotics. This is especially the case in the informal sector. Addressing Africa’s battle against substandard and falsified antibiotics requires an integrated approach building on current WHO, Interpol and Pan-African initiatives. Activities include harmonizing regulatory activities across Africa and increasing the monitoring of available antibiotics as well as fines and sanctions for offenders. In addition, reducing the current high levels of inappropriate antibiotic use makes the market for falsified and substandard antibiotics considerably less attractive.
KW - antibiotics
KW - antimicrobial resistance
KW - falsified antibiotics
KW - health authorities
KW - informal sector
KW - policy initiatives
KW - sub-Saharan Africa
KW - substandard antibiotics
UR - https://www.scopus.com/pages/publications/105018699713
U2 - 10.3389/fitd.2025.1634029
DO - 10.3389/fitd.2025.1634029
M3 - Article
AN - SCOPUS:105018699713
SN - 2673-7515
VL - 6
JO - Frontiers in Tropical Diseases
JF - Frontiers in Tropical Diseases
M1 - 1634029
ER -